IV Levetiracetam in Epilepsy
The FDA has approved an IV formulation of levetiracetam (Keppra tablet, UCB) solution as an infusion for the adjunctive use in the treatment of partial-onset seizures in adults with epilepsy. The 100-mg/ml injection is intended as an alternative when oral administration of levetiracetam is temporarily not feasible. When patients are switched from the oral to [...]
Read User's Comments